Who Owns IPHA?

Innate Pharma S.A. — Institutional Ownership & 13F Holdings

$1.46

-0.02 (-1.62%)

Market Cap

$150.9M

Shares Outstanding

93,829,180

Institutional Holders

10

Total Inst. Value

$2.5M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

3

Closed Positions

3

Increased

2

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GAMMA Investing LLCNew$2.2M3,975
2EXCHANGE TRADED CONCEPTS, LLC$112K62,752
3MORGAN STANLEY$77K43,524
4CITADEL ADVISORS LLC$43K24,267
5MILLENNIUM MANAGEMENT LLCNew$27K15,326
6UBS Group AG$16K9,001
7RHUMBLINE ADVISERS$1K675
8BARCLAYS PLC$1K307
9Optiver Holding B.V.$180101
10Tower Research Capital LLC (TRC)New$53

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
EXCHANGE TRADED CONCEPTS, LLC-15K$112K

Related Stocks

Frequently Asked Questions

How many institutional investors hold IPHA?

As of Q1 2025, 10 institutional investors report holding IPHA (Innate Pharma S.A.) in their 13F filings.

Which hedge fund owns the most IPHA?

The largest institutional holder of IPHA is GAMMA Investing LLC with $2.2M in shares.

Are institutions buying or selling IPHA?

This quarter, 3 institutions opened new positions in IPHA and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.